AEZS News and Press, Aeterna Zentaris Inc. From 02/15/24

2024-02-15 17:33:01 ET More on Aeterna Zentaris Aeterna Zentaris and Ceapro to merge in all-stock deal Seeking Alpha’s Quant Rating on Aeterna Zentaris Historical earnings data for Aeterna Zentaris Financial information for Aeterna Zentaris R...

2023-12-14 08:15:55 ET More on Aeterna Zentaris, Ceapro, etc. Seeking Alpha’s Quant Rating on Aeterna Zentaris Historical earnings data for Aeterna Zentaris Financial information for Aeterna Zentaris Financial information for Ceapro For further...

TORONTO and EDMONTON, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“ Aeterna ”) and Ceapro Inc. (TSXV: CZO) (OTCQX: CRPOF) (“ Ceapro ”), two innovative biopharmaceutical development companies, today announced that they h...

2023-11-09 08:56:55 ET More on Aeterna Zentaris Seeking Alpha’s Quant Rating on Aeterna Zentaris Historical earnings data for Aeterna Zentaris Financial information for Aeterna Zentaris For further details see: Aeterna Zentaris GAAP EPS of -$0.85

- Launch of Ghryvelin ™ in a number of key countries in the European Economic Area - Approval of Macrilen ® in South Korea in September - Ended the quarter with $38.8 million in cash, expected to fund operations and advancement of priority pipeline prog...

Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...

Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...

Aeterna Zentaris Inc. (AEZS) is expected to report $-0.61 for Q3 2023

– Live moderated webcast with Klaus Paulini, Chief Executive Officer of Aeterna Zentaris on Wednesday, October 25 th at 10:00 AM ET TORONTO, ONTARIO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the &...

TORONTO, ONTARIO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products,...